vs
Side-by-side financial comparison of FRANKLIN STREET PROPERTIES CORP (FSP) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
FRANKLIN STREET PROPERTIES CORP is the larger business by last-quarter revenue ($26.0M vs $20.4M, roughly 1.3× Sight Sciences, Inc.). Sight Sciences, Inc. runs the higher net margin — -20.4% vs -28.1%, a 7.7% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs -8.2%). Sight Sciences, Inc. produced more free cash flow last quarter ($-2.0M vs $-12.7M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs -8.7%).
Franklin Street Properties Corp is a Massachusetts-based real estate investment trust (REIT) in the United States. It primarily invests in, owns, and operates high-quality office properties across major U.S. metropolitan markets, serving corporate tenants across various industry segments, and delivers stable long-term returns via rental income and strategic asset management.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
FSP vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.0M | $20.4M |
| Net Profit | $-7.3M | $-4.2M |
| Gross Margin | 59.4% | 87.3% |
| Operating Margin | -27.9% | -18.0% |
| Net Margin | -28.1% | -20.4% |
| Revenue YoY | -8.2% | 6.9% |
| Net Profit YoY | 14.1% | 64.9% |
| EPS (diluted) | $-0.06 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.0M | $20.4M | ||
| Q3 25 | $27.3M | $19.9M | ||
| Q2 25 | $26.7M | $19.6M | ||
| Q1 25 | $27.1M | $17.5M | ||
| Q4 24 | $28.4M | $19.1M | ||
| Q3 24 | $29.7M | $20.2M | ||
| Q2 24 | $30.8M | $21.4M | ||
| Q1 24 | $31.2M | $19.3M |
| Q4 25 | $-7.3M | $-4.2M | ||
| Q3 25 | $-8.3M | $-8.2M | ||
| Q2 25 | $-7.9M | $-11.9M | ||
| Q1 25 | $-21.4M | $-14.2M | ||
| Q4 24 | $-8.5M | $-11.8M | ||
| Q3 24 | $-15.6M | $-11.1M | ||
| Q2 24 | $-21.0M | $-12.3M | ||
| Q1 24 | $-7.6M | $-16.3M |
| Q4 25 | 59.4% | 87.3% | ||
| Q3 25 | 60.9% | 86.4% | ||
| Q2 25 | 59.9% | 84.8% | ||
| Q1 25 | 62.8% | 86.2% | ||
| Q4 24 | 59.7% | 86.8% | ||
| Q3 24 | 61.0% | 83.9% | ||
| Q2 24 | 64.2% | 85.8% | ||
| Q1 24 | 64.7% | 85.5% |
| Q4 25 | -27.9% | -18.0% | ||
| Q3 25 | -30.5% | -39.7% | ||
| Q2 25 | -29.2% | -59.6% | ||
| Q1 25 | -78.9% | -79.2% | ||
| Q4 24 | -29.9% | -62.5% | ||
| Q3 24 | -52.4% | -55.7% | ||
| Q2 24 | -68.0% | -59.2% | ||
| Q1 24 | -24.0% | -76.4% |
| Q4 25 | -28.1% | -20.4% | ||
| Q3 25 | -30.5% | -41.0% | ||
| Q2 25 | -29.5% | -61.0% | ||
| Q1 25 | -79.1% | -80.8% | ||
| Q4 24 | -30.0% | -62.1% | ||
| Q3 24 | -52.6% | -54.9% | ||
| Q2 24 | -68.2% | -57.7% | ||
| Q1 24 | -24.2% | -84.4% |
| Q4 25 | $-0.06 | $-0.07 | ||
| Q3 25 | $-0.08 | $-0.16 | ||
| Q2 25 | $-0.08 | $-0.23 | ||
| Q1 25 | $-0.21 | $-0.28 | ||
| Q4 24 | $-0.09 | $-0.23 | ||
| Q3 24 | $-0.15 | $-0.22 | ||
| Q2 24 | $-0.20 | $-0.25 | ||
| Q1 24 | $-0.07 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $30.6M | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $607.0M | $63.9M |
| Total Assets | $892.9M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $30.6M | $92.0M | ||
| Q3 25 | $31.4M | $92.4M | ||
| Q2 25 | $29.4M | $101.5M | ||
| Q1 25 | $30.2M | $108.8M | ||
| Q4 24 | $41.1M | $120.4M | ||
| Q3 24 | $40.9M | $118.6M | ||
| Q2 24 | $30.2M | $118.2M | ||
| Q1 24 | $34.2M | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $607.0M | $63.9M | ||
| Q3 25 | $615.3M | $64.3M | ||
| Q2 25 | $624.7M | $70.0M | ||
| Q1 25 | $633.4M | $77.6M | ||
| Q4 24 | $655.9M | $87.5M | ||
| Q3 24 | $665.4M | $95.0M | ||
| Q2 24 | $682.1M | $101.6M | ||
| Q1 24 | $703.9M | $109.2M |
| Q4 25 | $892.9M | $115.3M | ||
| Q3 25 | $901.0M | $116.3M | ||
| Q2 25 | $903.2M | $122.0M | ||
| Q1 25 | $916.4M | $129.7M | ||
| Q4 24 | $946.9M | $142.8M | ||
| Q3 24 | $981.5M | $143.6M | ||
| Q2 24 | $1.0B | $149.7M | ||
| Q1 24 | $1.0B | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.8M | $-1.8M |
| Free Cash FlowOCF − Capex | $-12.7M | $-2.0M |
| FCF MarginFCF / Revenue | -48.6% | -9.7% |
| Capex IntensityCapex / Revenue | 63.0% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-25.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.8M | $-1.8M | ||
| Q3 25 | $8.3M | $-8.7M | ||
| Q2 25 | $-2.9M | $-7.5M | ||
| Q1 25 | $-5.5M | $-11.6M | ||
| Q4 24 | $9.0M | $-3.5M | ||
| Q3 24 | $14.5M | $362.0K | ||
| Q2 24 | $-648.0K | $-9.5M | ||
| Q1 24 | $-7.1M | $-9.8M |
| Q4 25 | $-12.7M | $-2.0M | ||
| Q3 25 | $3.0M | $-8.9M | ||
| Q2 25 | $-5.7M | $-7.8M | ||
| Q1 25 | $-9.9M | — | ||
| Q4 24 | $-16.2M | $-3.6M | ||
| Q3 24 | $8.6M | $311.0K | ||
| Q2 24 | $-5.1M | $-9.5M | ||
| Q1 24 | $-15.8M | $-9.9M |
| Q4 25 | -48.6% | -9.7% | ||
| Q3 25 | 11.0% | -44.7% | ||
| Q2 25 | -21.5% | -39.6% | ||
| Q1 25 | -36.7% | — | ||
| Q4 24 | -57.2% | -18.9% | ||
| Q3 24 | 29.1% | 1.5% | ||
| Q2 24 | -16.7% | -44.7% | ||
| Q1 24 | -50.8% | -51.4% |
| Q4 25 | 63.0% | 0.8% | ||
| Q3 25 | 19.4% | 0.9% | ||
| Q2 25 | 10.7% | 1.1% | ||
| Q1 25 | 16.4% | 0.0% | ||
| Q4 24 | 88.9% | 0.7% | ||
| Q3 24 | 19.6% | 0.3% | ||
| Q2 24 | 14.6% | 0.4% | ||
| Q1 24 | 28.1% | 0.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FSP
Segment breakdown not available.
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
